Qui Tam Litigation and Healthcare Fraud Update

The Federal False Claims Act is alive and well. Since Lara Silva’s original discussion on this topic in 2011, more whistleblowers are availing themselves of this potential jackpot in civil litigation.  

Since early in the 00’s many of the qui tam actions filed focused on the healthcare industry: pharmaceutical marketing practices, pricing of drugs, and durable medical equipment. Now, recently unsealed cases demonstrate that this litigation reaches to the provision of unnecessary services in various medical fields, military contracts, and the mortgage industry. 

Join Lara Silva, of The Silva Law Firm, as she discusses recent amendments to the law, recent case law, and how Defendants are rigorously mounting defenses to these actions. 

Learning Objectives:

I.     Understand the basics of the Federal False Claims Act

II.    Analyze amendments to the Act that impact the parties’ rights and actions

III.   Analyze recent case law

IV.   Understand the impact of choice of federal venue

V.    Analyze recent defense practice in the civil litigation of qui tam actions